Don Ressler is a business man who has succeed in most of his business ventures such as the intelligence beauty. In 2001 after his first business venture FittnessHeaven.com was purchased, Don Ressler teamed up with Adam Goldenberg to come up with Alena media. Don Ressler and Adam Goldenberg realized that they had the skills and knowledge that would help them in succeeding in the growing field of online advertising. In 2005 after their business was bought by the News Crop, Don Ressler, and his partner Adam Goldenberg left to explore new business ventures.
Don Ressler is the Chief Executive Officer and the co-founder of intelligent beauty. Intelligent Beauty launched another company by the name JustFab, in 2010.JustFab is an e-commerce industry that originated from United State. Techstyle fashion group which was formally known as Justfab at http://www.techstyle.com/happy-in-el-segundo-techstyle-coo-anton-von-rueden-on-the-perks-of-life-in-the-south-bay/, it is an online retail shop that deals with deals on shoes, handbag, and jewelry. It offers its customers a variety of preferences from the latest fashions and also gives its customers a personalized shopping experience. TechStyle Company is the parent company to other brands such as Fabletics and ShoeDazzle.
Don Ressler and Adam Goldenberg are the primary co-founders of JustFab online company. The company was founded in March 2010.In September 2011, Kimora Lee Simmons became the president and the creative director of JustFab Company. In 2011 JustFab received a funding of 33 million dollars from a United States capital firm, Matrix Partners. In 2012 JustFab moved internationally to countries such as Germany and Canada. This was as a result of 76 million dollars funds from several companies such as Technology Crossover Venture, Intelligent Beauty, Matrix Partners, and Rho Ventures. These funds greatly influenced the growth and success of JustFab Inc. In January 2013, JustFab acquired a children fashion company by the name FabKids and later celebrities started releasing their brands through Techstyle sub-brand on linkedin.com.
Brands such as Fabletics have resulted in fitness becoming more fashionable. Fabletics is one of the many JustFab brands. JustFab is the leading fashion site at Huffington Post that has made it in the e-commerce industry in the recent times. In the recent years, JustFab is on the way to generating 500 million dollars revenue, and Fabletics contributes almost 30% of this amount. This is the right track for a brand such as Fabletics which is merely two years old. JustFab closed 85 million dollars funding in August 2014 led by passport unique opportunity fund. This raised the company total capitalization to 250 million dollars.
With so much vast experience in different business environments, a man like Todd can only be considered best at what he does. Currently, Todd Lubar is president of the TLC, Global Ventures.
He has the upper hand in the understanding of business and its challenges, and how businesses are run in different environments. Todd Lubar has risen the ladder collecting extensive knowledge about the mortgage business. The demolition industry, the nightclub industry, the recycling industry as well as the Real estate development industry are just but a few examples of companies that Lubar has worked with.
He first joined the Real estate business in 1995, and it is here that he gained so much invaluable experiences. He learned how to form relationships and how to nurture them. He grew in this business by opening up Legendary Properties. The success of Legendary Properties enabled him to develop further by forming relationships with people he came in contact with and also with major banking institutions.
Lubar went a step further to use his funds to aid borrowers who otherwise would have been overlooked by traditional lending sources.
He has two beautiful children who live in Bethesda as well, with whom he likes spending time with and other family activities. As a person, Todd’s vision is to be a better person each and every day and improving the lives of the many people he comes in contact with in his businesses. This Vision can be clearly seen with the positive and encouraging messages he spreads on his social media, just to give hope and make people better.
Seattle Genetics has recently announced that they’re planning to increase its public stock offering from $480 million to $552 million. The Bothell-based biotech company plans on accomplishing this by exercising its over-allotment option. Clay Siegall, CEO of Seattle Genetics, said the decision was made after receiving an exceptional amount of interest from perspective investors. Seattle Genetics plans to use the stocks proceeds to continue the growth of the company’s people and infrastructure, in addition to further developing their drug pipeline and increasing the use of their cancer drug Adcetris.
The Biotech company will hire 100 people every year for the next few years and accommodate Seattle Genetics higher headcount (roughly 1,300 by 2020) by leasing a larger space in Canyon Park. Instead of focusing on a short-term goal of achieving profitable success, Siegall said Seattle Genetic’s lack of is not of any concern as they move forward with the company’s plan to expand their business and drug advancements for cancer and other diseases.
Seattle Genetics was co-founded by Clay Siegall in 1998 and currently ranks as the company’s Chief Executive Officer (CEO), President, and is a member of the Board of Directors as Chairman. Dr. Siegall has guided the biotech company’s capital by raising more than $330 million from public offerings, private financing, and other money-raising activities.
Clay Siegall received a B.S at the University of Maryland for Zoology and his Ph.D. at George Washington University for Genetics Dr. Siegall currently serves as one of the Board of Directors for the Washington Biotechnology and Biomedical Association (the WBBA) and Alder BioPharmaceuticals, in addition to his held positions at Seattle Genetics. He also serves as one of the Board of Governors for the Fred Hutchinson Cancer Business Alliance. Before his involvement with Seattle Genetics, Dr. Siegall worked for the National Institutes of Health and the National Cancer Institute from 1988 to 1991. Between 1991 to 1997, he worked for the Bristol-Myers Squibb Pharmaceutical Research Institute. In January of 2014, Siegall joined Ultragenyx as a board member.